FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Dr. Reddy's Laboratories Metoprolol Succinate Extended-Release Tablets Recall

Metoprolol Succinate Extended-Release Tablets, USP, 100 mg, 100 Tablets bottle, Rx only…

Dr. Reddy's Laboratories, Inc. · Princeton, NJ

Risk level
Class II
Reported by FDA
May 16, 2018
Recall ID
D-0727-2018
Check your lot numberHow we source this data

Summary

Dr. Reddy's Laboratories recalled Metoprolol Succinate Extended-Release Tablets starting Apr 23, 2018. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0727-2018 on May 16, 2018. Reason: Presence of Foreign Tablets/Capsules: One foreign tablet identified as Clopidogrel 75 mg was found in a 100 count bottle of Metoprolol Succiante Extended-Release Tablets. Status: Terminated.

Why it was recalled

Presence of Foreign Tablets/Capsules: One foreign tablet identified as Clopidogrel 75 mg was found in a 100 count bottle of Metoprolol Succiante Extended-Release Tablets.

Product description

Metoprolol Succinate Extended-Release Tablets, USP, 100 mg, 100 Tablets bottle, Rx only, Manufactured by: Dr. Reddy's Laboratories Limited Bachupally-500 090 India\ NDC 55111-468-01

Lot numbers, UPCs & expiration codes

Batch # C706254, 08/2019

Where it was sold

Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0727-2018
Classification
Class II
Status
Terminated
Recall initiated
Apr 23, 2018
FDA report date
May 16, 2018
Quantity
8160 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Dr. Reddy's Laboratories, Inc.

Original FDA data

Every field from FDA enforcement report D-0727-2018, exactly as published.

Show all FDA fields
City
Princeton
State
NJ
Status
Terminated
Country
United States
Event ID
79980
Address
107 College Rd E
Code information
Batch # C706254, 08/2019
Postal code
08540-6623
Report date
May 16, 2018
Product type
Drugs
Recall number
D-0727-2018
Classification
Class II
Recalling firm
Dr. Reddy's Laboratories, Inc.
Product quantity
8160 bottles
Termination date
Dec 14, 2020
Reason for recall
Presence of Foreign Tablets/Capsules: One foreign tablet identified as Clopidogrel 75 mg was found in a 100 count bottle of Metoprolol Succiante Extended-Release Tablets.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Metoprolol Succinate Extended-Release Tablets, USP, 100 mg, 100 Tablets bottle, Rx only, Manufactured by: Dr. Reddy's Laboratories Limited Bachupally-500 090 India\ NDC 55111-468-01
Distribution pattern
Nationwide
Recall initiation date
Apr 23, 2018
Initial firm notification
Letter
Center classification date
May 9, 2018

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0727-2018, published May 16, 2018. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls